PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
43.31%
Revenue growth 1.25-1.5x FSLR's 35.73%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
28.15%
Gross profit growth above 1.5x FSLR's 13.26%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
-38.47%
Negative EBIT growth while FSLR is at 17.27%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
573.02%
Operating income growth above 1.5x FSLR's 17.27%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
423.62%
Net income growth above 1.5x FSLR's 11.21%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
423.08%
EPS growth above 1.5x FSLR's 11.23%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
423.08%
Diluted EPS growth above 1.5x FSLR's 10.87%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.29%
Share count expansion well above FSLR's 0.26%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
10.55%
Diluted share count expanding well above FSLR's 0.24%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
57.45%
OCF growth under 50% of FSLR's 225.02%. Michael Burry might suspect questionable revenue recognition or rising costs.
73.33%
FCF growth under 50% of FSLR's 293.06%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
No Data
No Data available this quarter, please select a different quarter.
628.87%
5Y revenue/share CAGR under 50% of FSLR's 3854.50%. Michael Burry would suspect a significant competitive gap or product weakness.
90.49%
3Y revenue/share CAGR under 50% of FSLR's 346.32%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-150.34%
Negative 5Y OCF/share CAGR while FSLR is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-68.28%
Negative 3Y OCF/share CAGR while FSLR stands at 172.71%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
No Data
No Data available this quarter, please select a different quarter.
457.79%
Below 50% of FSLR's 40527.00%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
93.42%
Below 50% of FSLR's 241.73%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
371.33%
Equity/share CAGR of 371.33% while FSLR is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
37.60%
Below 50% of FSLR's 199.38%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-17.97%
Firm’s AR is declining while FSLR shows 28.46%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
7.14%
We show growth while FSLR is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-15.11%
Negative asset growth while FSLR invests at 15.71%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-2.77%
We have a declining book value while FSLR shows 9.31%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-41.06%
We’re deleveraging while FSLR stands at 80.62%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
19.42%
We increase R&D while FSLR cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
-2.90%
We cut SG&A while FSLR invests at 12.96%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.